We See a Way to
accelerate biomarker discovery by reducing hands-on sample preparation time by up to 2.5 hours*
Biomek i3, Biomek i5, Biomek i7 Automated Workstations
Accelerating Biomarker Discovery with Scalable Laboratory Automation
Accelerating Biomarker Discovery Through Scalable Automation
Biomarker discovery workflows often require the processing of hundreds to thousands of samples across multiple analytes, including proteins, nucleic acids, metabolites, and cellular markers. Manual sample preparation involves repetitive tasks such as aliquoting, reagent addition, normalization, extraction, purification, and assay setup, all of which can introduce variability and limit throughput. As study sizes grow, laboratories need automated solutions that deliver consistent results while enabling researchers to scale operations efficiently .
The Biomek i-Series Automated Liquid Handling Workstations address these challenges by automating critical sample preparation steps, enabling biomarker discovery laboratories to achieve greater throughput, accuracy, and consistency. With highly precise liquid handling capabilities, the platform minimizes pipetting errors and ensures uniform processing across all samples, reducing variability that can mask biologically relevant signals.
The flexibility of the Biomek i-Series workstations allows researchers to automate a wide range of biomarker discovery applications, including next-generation sequencing (NGS) library preparation, nucleic acid extraction, protein sample preparation, ELISA workflows, and multi-omics studies. Its open-platform design seamlessly integrates with laboratory instruments such as plate readers, incubators, thermocyclers, and analytical systems, creating streamlined end-to-end workflows with minimal manual intervention.
Advanced software tools simplify method development and workflow optimization, enabling laboratories to quickly adapt protocols to evolving research needs. Automated tracking and standardized execution improve data integrity, support regulatory compliance, and enhance reproducibility across operators, laboratories, and studies.
By reducing hands-on sample preparation time by up to 2.5 hours* and increasing operational efficiency, the Biomek i-Series workstations enable scientists to spend less time on routine processing and more time interpreting data, validating biomarkers, and advancing research programs. Faster turnaround times, improved reproducibility, and scalable automation help accelerate the path from sample to actionable biological insight.
Key Benefits for Biomarker Discovery
- Automates high-throughput sample preparation for large biomarker studies.
- Reduces human error enabling scientists to focus on higher-value research activities.
- Improves reproducibility through standardized and consistent workflow execution.
- Minimizes pipetting errors and sample-to-sample variability to improve data quality.
- Supports multi-omics workflows, including genomics, proteomics, metabolomics, and translational research applications.
- Seamlessly integrates with laboratory instruments for streamlined end-to-end automation.
- Scales easily from pilot studies to large population-based research programs.
- Accelerates time-to-results, enabling faster biomarker identification, validation, and decision-making.
In biomarker discovery environments where data quality, reproducibility, and throughput are critical, the Biomek i-Series workstations serve as a powerful automation platform that transforms sample preparation into a reliable, scalable, and efficient process.
*Archer FUSIONPlex Application on Biomek i3 workstation. Timings may vary based on application and system.
Speak to one of our leading life sciences experts
TTAE
TTAE
546006278
TTAE
add
Talk to an Expert
https://lifesciences.danaher.com/
https://lifesciences.danaher.com/us/en/solutions/gene-therapy/crispr-gene-mediated.html